In last trading session, Metagenomi Inc (NASDAQ:MGX) saw 0.39 million shares changing hands with its beta currently measuring -2.54. Company’s recent per share price level of $2.36 trading at -$0.08 or -3.28% at ring of the bell on the day assigns it a market valuation of $88.32M. That closing price of MGX’s stock is at a discount of -429.66% from its 52-week high price of $12.50 and is indicating a premium of 31.78% from its 52-week low price of $1.61.
For Metagenomi Inc (MGX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.25. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.78 in the current quarter.
Metagenomi Inc (NASDAQ:MGX) trade information
Upright in the red during last session for losing -3.28%, in the last five days MGX remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $2.36 price level, adding 16.31% to its value on the day. Metagenomi Inc’s shares saw a change of -34.63% in year-to-date performance and have moved -3.67% in past 5-day. Metagenomi Inc (NASDAQ:MGX) showed a performance of -22.11% in past 30-days.
Wall Street analysts have assigned a consensus price target of 14.5 to the stock, which implies a rise of 83.72% to its current value. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 22. It follows that stock’s current price would drop -196.61% in reaching the projected high whereas dropping to the targeted low would mean a loss of -196.61% for stock’s current value.
Metagenomi Inc (MGX) estimates and forecasts
This year revenue growth is estimated to rise 15.51% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 9.46M for the same. And 2 analysts are in estimates of company making revenue of 6.25M in the next quarter. Company posted 12.4M and 11.16M of sales in current and next quarters respectively a year earlier.
In 2025, company’s earnings growth rate is likely to be around 87.64% while estimates for its earnings growth in next 5 years are of 50.88%.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 177.21 shares of worth $0.42 million or 0.47% of the total outstanding shares. The later fund manager was in possession of 176.87 shares on Nov 30, 2024 , making its stake of worth around $0.42 million in the company or a holder of 0.47% of company’s stock.
